Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × Dalteparin × Clear all

NCT00323011 2014-05-21

FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer

Phase 2 Terminated

Gastrointestinal

Colorectal Neoplasms